首页> 外国专利> HUMAN 8-OXODEOXYGUANOSINE TRIPHOSPHATASE, CDNA CODING THE ENZYME AND CDNA CLONE

HUMAN 8-OXODEOXYGUANOSINE TRIPHOSPHATASE, CDNA CODING THE ENZYME AND CDNA CLONE

机译:人8-OXODEOXYGUANOSINE磷酸酶,编码酶的CDNA和CDNA克隆

摘要

PURPOSE: To obtain a new enzyme 8-oxodGTPase extracted and purified from cultured human cell and active to suppress the mutation and carcinogenesis of human cell. ;CONSTITUTION: This human-originated 8-oxodGTPase is a protein extracted and purified from cultured human cell, preferably a cell strain originated from cancer cell and contains the peptide composed at least of the amino acid sequences of the formula I, the formula II (Xaa is Asp or Trp), the formula III, the formula IV (1st Xaa is Ser or Asp; 11th Xaa is Pro or Gin; 12th Xaa is Ile, Leu or Ala; 14th Xaa is unknown) and the formula V. It is produced by a cDNA clone receptor cell transformed with a cDNA clone [e.g. plasmid p24T existing in E.coli SURE/p24T (FERM P-13676)] obtained by integrating a cDNA coding the enzyme into a vector. Cancer induced by the point mutation of a gene DNA can be suppressed by expressing the cDNA in the living body.;COPYRIGHT: (C)1995,JPO
机译:目的:获得一种从培养的人细胞中提取纯化的新酶8-oxodGTPase,该酶具有抑制人细胞突变和致癌作用。 ;组成:这种源自人类的8-oxodGTPase是从培养的人细胞(优选是源自癌细胞的细胞株)中提取和纯化的蛋白质,并且包含至少由式I,式II( Xaa是Asp或Trp),式III,式IV(第一个Xaa是Ser或Asp;第11个Xaa是Pro或Gin;第12个Xaa是Ile,Leu或Ala;第14个Xaa是未知的)和式V.由用cDNA克隆转化的cDNA克隆受体细胞产生的[例如存在于大肠杆菌SURE / p24T中的质粒p24T(FERM P-13676)]是通过将编码酶的cDNA整合到载体中而获得的。基因DNA的点突变诱导的癌症可以通过在体内表达cDNA来抑制。;版权所有:(C)1995,JPO

著录项

  • 公开/公告号JPH0723782A

    专利类型

  • 公开/公告日1995-01-27

    原文格式PDF

  • 申请/专利权人 RES DEV CORP OF JAPAN;

    申请/专利号JP19930173431

  • 发明设计人 SEKIGUCHI MUTSUO;TSUZUKI TERUHISA;

    申请日1993-07-13

  • 分类号C12N9/12;C12N1/21;C12N15/09;

  • 国家 JP

  • 入库时间 2022-08-22 04:24:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号